Article
  • Characteristics of Nifedipine Loaded PLGA Wafer
  • Seo SA, Choi HS, Lee DH, Khang G, Lee HB
  • 니페디핀을 함유한 생분해성 PLGA 웨이퍼의 제조와 특성분석
  • 서선아, 최학수, 이동헌, 강길선, 이해방
References
  • 1. Kroeber S, Schomerus C, Korf HW, Brain Res., 744, 68 (1997)
  •  
  • 2. Hayase N, Itagaki YI, Ogawa S, Akutsu S, Inagaki S, Abiko Y, J. Pharm. Sci., 83, 532 (1994)
  •  
  • 3. Grundy JS, Kherani R, Foster RT, J. Pharm. Biomed. Anal., 12, 1529 (1994)
  •  
  • 4. Trippel SB, J. Bone Joint Surg., 68A, 1297 (1986)
  •  
  • 5. Tateshita K, Sugawara S, Imai T, Otagiri M, Biomed. Pharm. Bull., 16, 420 (1993)
  •  
  • 6. Chandy T, Sharma CP, Biomaterials, 13, 949 (1992)
  •  
  • 7. Sansdrap P, Moes AJ, Int. J. Pharm., 98, 157 (1993)
  •  
  • 8. Bakai A, Pathak YV, Benita S, Drug Dev. Ind. Pharm., 16, 2057 (1990)
  •  
  • 9. Chuo WH, Tsai TR, Hsu SH, Cham TM, Int. J. Pharm., 144, 241 (1996)
  •  
  • 10. Cho JC, Khang G, Rhee JM, Kim YS, Lee JS, Lee HB, Korea Polym. J., 7(2), 79 (1999)
  •  
  • 11. Khang G, Cho JC, Lee JW, Rhee JM, Lee HB, Bio-Med. Mater. Eng., 9(1), 49 (1999)
  •  
  • 12. Khang G, Cho JC, Rhee JM, Lee JS, Lee HB, Polym. Prepr., 40, 288 (1999)
  •  
  • 13. Lee HB, Khang G, Cho JC, Rhee JM, Lee JSFentany1-loaded PLGA Microspheres for Local Anesthesia, in Controlled Drug Delivery; Designing Technologies for the Future, eds. by K. Park and R.J. Mrnsyin, p. 385, ACS Symp. Series 752, ACS, Washington D.C., 2000 (2000)
  •  
  • 14. Bissery MC, Valeriote F, Thies CIn vitro and in vivo Evaluation of BCNU-loaded Microspheres Prepared from Poly((D-L)-lactide) and Poly(β- hydroxybutyrate), in Microspheres and Drug Therapy; Pharmaceutical, Immunological and Medical Aspects, eds. by S.S. Davis, L. Illum, J.G. McVie, and T. linson, p. 217, Elsevier Sci., New York, 1984 (1984)
  •  
  • 15. Juni K, Nakano M, CRC Crit. Rev. Therap. Drug Carrier Syst., 3, 209 (1987)
  •  
  • 16. Atkins TW, Peacock SJ, J. Microencapsul., 13(6), 709 (1996)
  •  
  • 17. Mauduit J, Buhk N, Vert M, J. Control. Release, 23, 221 (1993)
  •  
  • 18. Khang G, Choi HS, Rhee JM, Yoon SC, Cho JC, Lee HB, Korea Polym. J., 8(6), 253 (2000)
  •  
  • 19. Choi HS, Kim SW, Yun DI, Khang G, Rhee JM, Kim YS, Lee HB, Polym.(Korea), 25(3), 334 (2001)
  •  
  • 20. Sansolrap P, Moes AJ, J. Control. Release, 43 (1997)
  •  
  • 21. Akhtar S, Pouton CW, Drug News Perspectives, 2, 89 (1989)
  •  
  • 22. Chaudhary RS, Gangwal SS, Gupta VK, Shah YN, Jindal KC, Khanna S, Drug Dev. Ind. Pharm., 23, 1267 (1994)
  •  
  • 23. Grundy JS, Anderson KE, Rogers JA, Foster RT, J. Control. Release, 48, 1 (1997)
  •  
  • 24. Mark NThe United States Pharmacopeia (USP), 23, United States Pharmacopeial Convention, Inc., Rockville, MD, 1995 (1995)
  •  
  • 25. Abou-Auda HS, Najjar TA, Al-Khamis KI, Al-Hadiya BM, Ghilzai NM, Al-Fawzan NF, J. Pharm. Biomed. Anal., 22, 241 (2000)
  •  
  • 26. Maggi L, Torre ML, Giunche P, Conte U, Int. J. Pharm., 135, 73 (1996)
  •  
  • 27. Hausberger AG, DeLuca PP, J. Pharm. Biomed. Anal., 13, 747 (1995)
  •  
  • 28. Akhtar S, Pouton CW, Notarianni LJ, Gould PL, J. Pharm. Pharmacol., 40, 118 (1988)
  •  
  • 29. Gopferich AMechanisms of Polymer Degradation and Elimination, in Handbook of Biodegradable Polymers, eds. by A.J. Domb, J. Kost, and D.M. Wisemanin, p. 458, London, 2000 (2000)
  •  
  • 30. Okada H, Toguchi H, CRC Crit. Rev. Therap. Drug Carrier Syst., 12, 1 (1995)
  •  
  • Polymer(Korea) 폴리머
  • Frequency : Bimonthly(odd)
    ISSN 0379-153X(Print)
    ISSN 2234-8077(Online)
    Abbr. Polym. Korea
  • 2023 Impact Factor : 0.4
  • Indexed in SCIE

This Article

  • 2001; 25(6): 884-892

    Published online Nov 25, 2001

  • 10.7317/pk.
  • Received on Aug 7, 2001
  • Revised on Nov 30, -0001
  • Accepted on Nov 30, -0001

Correspondence to

  • E-mail: